Author:
Remschmidt Helmut,Hennighausen K.,Heiset P.,Clement W.,Schulz E.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Developmental and Educational Psychology,General Medicine,Pediatrics, Perinatology, and Child Health
Reference55 articles.
1. Abczynska M, Kazmirek Z, Syguda J, Terminska K (1995) Own experience (1989–1994) in the treatment of adolescent schizophrenic paranoid syndromes with Leponex produced by Sandoz Company. Psychiatria Polska 29: 79–85
2. Aravagiri M, Marder SR, Wirshing D, Wirshing WC (1998) Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in schizophrenic patients: simultaneous determination by a high performance liquid chromatography with electrochemical detection. Pharmacopsychiatry 31: 102–109
3. Armenteros JL, Whitaker AH, Welikson M, Stedge DJ, Gorman J (1997) Risperidone in adolescents with schizophrenia: an open pilot study. Journal of the American Academy of Child & Adolescent Psychiatry 36: 694–700
4. Beasley CM, Tollefson GD, Tran P, Satterlee W, Sanger T, Holman S, The Olanzapine HGAD Study Group (1996) Olanzapine versus placebo and haloperidol; acute phase results of the North American double blind olanzapine trial. Neuropsychopharmacology 14: 111–123
5. Blanz B, Schmidt MH (1993) Clozapine for schizophrenia [letter; comment]. Journal of the American Academy of Child & Adolescent Psychiatry 32: 223–224
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献